Other Viruses Citation List: March 27 - April 9, 2015

Hepatitis B Virus

1. Chemical Constituents of Swertia mussotii and Their anti-Hepatitis B Virus Activity. Cao, T.W., C.A. Geng, Y.B. Ma, X.M. Zhang, J. Zhou, Y.D. Tao, and J.J. Chen. Fitoterapia, 2015. 102: p. 15-22. PMID[25665940].

[PubMed]. OV_0327-040915.

2. Influence of the Basal Core Promoter and Precore Mutation on Replication of Hepatitis B Virus and Antiviral Susceptibility of Different Genotypes. Cui, X.J., Y.K. Cho, and B.C. Song. Journal of Medical Virology, 2015. 87(4): p. 601-608. PMID[25612255].

[PubMed]. OV_0327-040915.

3. Synthesis of Erythrocentaurin Derivatives as a New Class of Hepatitis B Virus Inhibitors. Geng, C.A., X.Y. Huang, Y.B. Ma, X.M. Zhang, and J.J. Chen. Bioorganic & Medicinal Chemistry Letters, 2015. 25(7): p. 1568-1571. PMID[25737009].

[PubMed]. OV_0327-040915.

4. Five New Secoiridoid Glycosides and One Unusual Lactonic Enol Ketone with anti-HBV Activity from Swertia cincta. Jie, X.X., C.A. Geng, X.Y. Huang, Y.B. Ma, X.M. Zhang, R.P. Zhang, and J.J. Chen. Fitoterapia, 2015. 102: p. 96-101. PMID[25721422].

[PubMed]. OV_0327-040915.

5. Transbody against Hepatitis B Virus Core Protein Inhibits Hepatitis B Virus Replication in Vitro. Wang, Y., Y. Li, N. Li, Q. Zhu, L. Hui, X. Liu, Q. Han, Y. Lv, Q. Wang, G. Yang, Z. Zhou, and Z. Liu. International Immunopharmacology, 2015. 25(2): p. 363-369. PMID[25676532].

[PubMed]. OV_0327-040915.

6. Isolation, Synthesis and anti-Hepatitis B Virus Evaluation of P-Hydroxyacetophenone Derivatives from Artemisia capillaris. Zhao, Y., C.A. Geng, H. Chen, Y.B. Ma, X.Y. Huang, T.W. Cao, K. He, H. Wang, X.M. Zhang, and J.J. Chen. Bioorganic & Medicinal Chemistry Letters, 2015. 25(7): p. 1509-1514. PMID[25737008].

[PubMed]. OV_0327-040915.

7. A Coumarin Lignanoid from the Stems of Kadsura heteroclita. Su, W., J. Zhao, M. Yang, H.W. Yan, T. Pang, S.H. Chen, H.Y. Huang, S.H. Zhang, X.C. Ma, D.A. Guo, I.A. Khan, and W. Wang. Bioorganic & Medicinal Chemistry Letters, 2015. 25(7): p. 1506-1508. PMID[25736995].

[PubMed]. OV_0327-040915.

Hepatitis C Virus

8. Synthesis and Biological Evaluation of alpha-Aryl-alpha-tetralone Derivatives as Hepatitis C Virus Inhibitors. Manvar, D., A. Fernandes Tde, J.L. Domingos, E. Baljinnyam, A. Basu, E.F. Junior, P.R. Costa, and N. Kaushik-Basu. European Journal of Medicinal Chemistry, 2015. 93: p. 51-54. PMID[25644675].

[PubMed]. OV_0327-040915.

9. P2-Quinazolinones and bis-Macrocycles as New Templates for Next-generation Hepatitis C Virus NS3/4A Protease Inhibitors: Discovery of MK-2748 and MK-6325. Rudd, M.T., J.W. Butcher, K.T. Nguyen, C.J. McIntyre, J.J. Romano, K.F. Gilbert, K.J. Bush, N.J. Liverton, M.K. Holloway, S. Harper, M. Ferrara, M. DiFilippo, V. Summa, J. Swestock, J. Fritzen, S.S. Carroll, C. Burlein, J.M. DiMuzio, A. Gates, D.J. Graham, Q. Huang, S. McClain, C. McHale, M.W. Stahlhut, S. Black, R. Chase, A. Soriano, C.M. Fandozzi, A. Taylor, N. Trainor, D.B. Olsen, P.J. Coleman, S.W. Ludmerer, and J.A. McCauley. ChemMedChem, 2015. 10(4): p. 727-735. PMID[25759009].

[PubMed]. OV_0327-040915.

10. Interactions of the Hepatitis C Virus Protease Inhibitor Faldaprevir with Cytochrome P450 Enzymes: In Vitro and in Vivo Correlation. Sabo, J.P., J. Kort, C. Ballow, A.D. Kashuba, M. Haschke, M. Battegay, B. Girlich, N. Ting, B. Lang, W. Zhang, C. Cooper, D. O'Brien, E. Seibert, T.S. Chan, D. Tweedie, and Y. Li. Journal of Clinical Pharmacology, 2015. 55(4): p. 467-477. PMID[25449227].

[PubMed]. OV_0327-040915.

11. Discovery of Imidazo[2,1-b]thiazole HCV NS4B Inhibitors Exhibiting Synergistic Effect with Other Direct-acting Antiviral Agents. Wang, N.Y., Y. Xu, W.Q. Zuo, K.J. Xiao, L. Liu, X.X. Zeng, X.Y. You, L.D. Zhang, C. Gao, Z.H. Liu, T.H. Ye, Y. Xia, Y. Xiong, X.J. Song, Q. Lei, C.T. Peng, H. Tang, S.Y. Yang, Y.Q. Wei, and L.T. Yu. Journal of Medicinal Chemistry, 2015. 58(6): p. 2764-2778. PMID[25710739].

[PubMed]. OV_0327-040915.

12. Discovery of anti-Claudin-1 Antibodies as Candidate Therapeutics against Hepatitis C Virus. Yamashita, M., M. Iida, M. Tada, Y. Shirasago, M. Fukasawa, S. Nagase, A. Watari, A. Ishii-Watabe, K. Yagi, and M. Kondoh. The Journal of Pharmacology and Experimental Therapeutics, 2015. 353(1): p. 112-118. PMID[25628391].

[PubMed]. OV_0327-040915.

Simian Immunodeficiency Virus

13. Simian-tropic HIV as a Model to Study Drug Resistance against Integrase Inhibitors. Wares, M., S. Hassounah, T. Mesplede, P.A. Sandstrom, and M.A. Wainberg. Antimicrobial Agents and Chemotherapy, 2015. 59(4): p. 1942-1949. PMID[25583721].

[PubMed]. OV_0327-040915.

Epstein-Barr Virus

14. Neo-clerodane Diterpenoids from Scutellaria barbata with Activity against Epstein-Barr Virus Lytic Replication. Wu, T., Q. Wang, C. Jiang, S.L. Morris-Natschke, H. Cui, Y. Wang, Y. Yan, J. Xu, K.H. Lee, and Q. Gu. Journal of Natural Products, 2015. 78(3): p. 500-509. PMID[25647077].

[PubMed]. OV_0327-040915.

Human Cytomegalovirus

15. A Novel CDK7 Inhibitor of the Pyrazolotriazine Class Exerts Broad-spectrum Antiviral Activity at Nanomolar Concentrations. Hutterer, C., J. Eickhoff, J. Milbradt, K. Korn, I. Zeittrager, H. Bahsi, S. Wagner, G. Zischinsky, A. Wolf, C. Degenhart, A. Unger, M. Baumann, B. Klebl, and M. Marschall. Antimicrobial Agents and Chemotherapy, 2015. 59(4): p. 2062-2071. PMID[25624324].

[PubMed]. OV_0327-040915.

Citations from the ISI Web of Knowledge Listings for O.V.

16. HPLC Analysis and Antimicrobial, Antimycobacterial and Antiviral Activities of Tabernaemontana catharinensis A. DC. Boligon, A.A., M. Piana, T.F. Kubica, D.N. Mario, T.V. Dalmolin, P.C. Bonez, R. Weiblen, L. Lovato, S.H. Alves, M.M.A. Campos, and M.L. Athayde. Journal of Applied Biomedicine, 2015. 13(1): p. 7-18. ISI[000350670600008].

[WOS]. OV_0327-040915.

17. Rescuing Compound Bioactivity in a Secondary Cell-based Screening by Using Gamma-cyclodextrin as a Molecular Carrier. Claveria-Gimeno, R., S. Vega, V. Grazu, J.M. de la Fuente, A. Lanas, A. Velazquez-Campoy, and O. Abian. International Journal of Nanomedicine, 2015. 10: p. 2249-2259. ISI[000351218300003].

[WOS]. OV_0327-040915.

18. Investigation of the Antiviral Bioactivity of Lactobacillus bulgaricus 761N Extracellular Extract against Hepatitis C Virus (HCV). El-Adawi, H., I. Nour, F. Fattouh, and N. El-Deeb. International Journal of Pharmacology, 2015. 11(1): p. 19-26. ISI[000351019500003].

[WOS]. OV_0327-040915.

19. Design, Synthesis, and Antiviral Activity of Novel Rutin Derivatives Containing 1, 4-Pentadien-3-one Moiety. Han, Y., Y. Ding, D.D. Xie, D.Y. Hu, P. Li, X.Y. Li, W. Xue, L.H. Jin, and B. Song. European Journal of Medicinal Chemistry, 2015. 92: p. 732-737. ISI[000350919100060].

[WOS]. OV_0327-040915.

20. Aptamers in Diagnostics and Treatment of Viral Infections. Wandtke, T., J. Wozniak, and P. Kopinski. Viruses, 2015. 7(2): p. 751-780. ISI[000350670800017].

[WOS]. OV_0327-040915.